Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere.
Publication
, Journal Article
Woodward, DF; Wang, JW; Stamer, WD; Lütjen-Drecoll, E; Krauss, AH-P; Toris, CB
Published in: J Ocul Pharmacol Ther
November 2019
For >2 decades, EP2 agonists have been the subject of antiglaucoma research and development by scientists in industry and academia around the world. The road has led to the recent approval of the first drug of this class. This article reviews the development of EP2 agonists from conception to clinical approval, discussing pharmacology, structure, biodistribution, therapeutics, and drug delivery. An extensive list of source references is provided for the reader's benefit.
Duke Scholars
Published In
J Ocul Pharmacol Ther
DOI
EISSN
1557-7732
Publication Date
November 2019
Volume
35
Issue
9
Start / End Page
469 / 474
Location
United States
Related Subject Headings
- Receptors, Prostaglandin E, EP2 Subtype
- Ophthalmology & Optometry
- Humans
- Glaucoma
- Drug Delivery Systems
- Antihypertensive Agents
- Animals
- 3214 Pharmacology and pharmaceutical sciences
- 3212 Ophthalmology and optometry
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Woodward, D. F., Wang, J. W., Stamer, W. D., Lütjen-Drecoll, E., Krauss, A.-P., & Toris, C. B. (2019). Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere. J Ocul Pharmacol Ther, 35(9), 469–474. https://doi.org/10.1089/jop.2019.0041
Woodward, David F., Jenny W. Wang, W Daniel Stamer, E. Lütjen-Drecoll, Achim H-P Krauss, and Carol B. Toris. “Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere.” J Ocul Pharmacol Ther 35, no. 9 (November 2019): 469–74. https://doi.org/10.1089/jop.2019.0041.
Woodward DF, Wang JW, Stamer WD, Lütjen-Drecoll E, Krauss AH-P, Toris CB. Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere. J Ocul Pharmacol Ther. 2019 Nov;35(9):469–74.
Woodward, David F., et al. “Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere.” J Ocul Pharmacol Ther, vol. 35, no. 9, Nov. 2019, pp. 469–74. Pubmed, doi:10.1089/jop.2019.0041.
Woodward DF, Wang JW, Stamer WD, Lütjen-Drecoll E, Krauss AH-P, Toris CB. Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere. J Ocul Pharmacol Ther. 2019 Nov;35(9):469–474.
Published In
J Ocul Pharmacol Ther
DOI
EISSN
1557-7732
Publication Date
November 2019
Volume
35
Issue
9
Start / End Page
469 / 474
Location
United States
Related Subject Headings
- Receptors, Prostaglandin E, EP2 Subtype
- Ophthalmology & Optometry
- Humans
- Glaucoma
- Drug Delivery Systems
- Antihypertensive Agents
- Animals
- 3214 Pharmacology and pharmaceutical sciences
- 3212 Ophthalmology and optometry
- 1115 Pharmacology and Pharmaceutical Sciences